Targeted dosing to treat pediatric inflammatory bowel disease is challenging because dosing guidelines are based on data gathered from adult subjects of clinical trials. Patients’ families and health care organizations also incur high costs and must try to balance potential benefits against risks of ongoing monitoring.
AMA J Ethics. 2018;20(9):E841-848. doi:
10.1001/amajethics.2018.841.
In order to successfully resolve ethical conflicts, bioethics consultants must pay attention to process and heed stakeholders’ perspectives and values.
AMA J Ethics. 2016;18(5):485-492. doi:
10.1001/journalofethics.2016.18.5.ecas2-1605.
Dr Joshua D. Safer joins Ethics Talk to discuss his article, coauthored with Rebkah Tesfamariam: “How Should a Transgender Patient’s History of Deep Vein Thrombosis and Smoking Influence Gender-Affirming Health Decision Sharing?”
Dr Patricia Luck joins Ethics Talk to discuss her article, coauthored with Arman M. Niknafs: “Reasons Not to Turf a Patient Whose ‘Belonging’ in a Hospital Is Unclear.”
Dr Christy A. Rentmeester joins Ethics Talk to discuss her article: “How to Gird Up ‘Watch One, Do One, Teach One’ for the Moral Psychological Demands of Just Action.”